Silke Tannapfel, former Administrative Director, will leave the Helmholtz Centre for Infection Research (HZI) in Braunschweig on 31 December 2021 to take on new professional challenges as Ministerial Director in the...
The increasing spread of resistant germs means that formerly highly effective antibiotics are often not successful anymore in treating infectious diseases. To counteract this development, the team led by Prof. Anna...
Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Cambridge have revealed the molecular details of a genetic switch through their work on the 2A protein...
The rapid expansion of the Omicron variant has taken the international medical and scientific community by surprise. After infection or vaccination against the coronavirus, our bodies produce antibodies that play a key...
Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig demonstrate for the first time how ZAP, a protein of the...
Since 2017, interested citizen scientists can collect soil samples as part of the "Sample’ das Saarland" campaign and send them to the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site...
Between July 2020 and August 2021, the Epidemiology Department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig examined the blood of approximately 26,000 individuals for antibodies against the...
A conversation about the direction of research at the HZI with Prof Thomas Pietschmann, who is the head of the "Experimental Virology" department at the HZI and director of the Experimental Virology Institute at the...
The cold season has arrived along with the question of whether a vaccination against influenza makes sense in times of the ongoing pandemic. And when is the right time for the third vaccination, i.e. the booster...
